Professor Andrew Wilks has founded a new biotech fund targeting local early-stage medical research The fund, Synthesis Bioventures, aims to raise $75 million and so far has invested $15 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback